Vimarsana
Biggest News Aggregation in the World

Page 3 - Second Harmonic Generation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Second Harmonic Generation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Second Harmonic Generation Today - Breaking & Trending Today

VLSI Manufacturing Metrology, Inspection, and Process Control Market Report 2021: Chipmakers Remain Committed to Their Capex and Shrinkage Plans for Now - Vimarsana News

VLSI Manufacturing Metrology, Inspection, and Process Control Market Report 2021: Chipmakers Remain Committed to Their Capex and Shrinkage Plans for Now

/PRNewswire/ --The "Metrology, Inspection, and Process Control in VLSI Manufacturing" report from The Information Network has been added to...

Gattefossé x BioMeca Develop 3D Dermal Microtissue to Study Elasticity - Vimarsana News

Gattefossé x BioMeca Develop 3D Dermal Microtissue to Study Elasticity

Gattefossé x BioMeca Develop 3D Dermal Microtissue to Study Elasticity March 16, 2021 Contact Author Michele Behrens Close Gattefossé and BioMeca jointly developed a model of 3D dermal microtissue to study elastic properties in vitro. Sponsored   3D, spheroid-based, scaffold-free microtissues were created by Gattefossé to mimic and study the intrinsic elastic properties of the dermis in vitro. BioMeca then leveraged its expertise to analyze the substrates, the dynamics therein and potential actives of interest. According to Gattefossé, during aging, human skin undergoes alt...

HistoIndex and Consortium Partners Awarded S$1.2M for the Development of AI-based Diagnostics Tool in the Identification of High-Risk Nonalcoholic Fatty Liver Disease Population - Vimarsana News

HistoIndex and Consortium Partners Awarded S$1.2M for the Development of AI-based Diagnostics Tool in the Identification of High-Risk Nonalcoholic Fatty Liver Disease Population

Share this article Share this article HistoIndex joins forces with a consortium of partners from NHS Health Boards, UK universities and technology companies for the development of a novel AI-based integrated diagnostic tool. There is currently no available method to accurately identify patients with NAFLD who are at a higher risk of developing a more progressive form of liver disease (non-alcoholic steatohepatitis or NASH) that can lead to cirrhosis, liver cancer and premature death. NASH is an unmet liver condition that awaits an FDA-approved treatment. Having an AI-based diagnostics tool ...